Facial synthesis of key intermediate of obeticholic acid via Pd-catalyzed Kumada-Tamao-Corriu cross-coupling reaction
- 18 May 2020
- journal article
- research article
- Published by Elsevier BV in Steroids
- Vol. 160, 108657
- https://doi.org/10.1016/j.steroids.2020.108657
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialThe Lancet, 2015
- Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic ratsJournal of Hepatology, 2013
- Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acidsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2013
- An improved synthesis of 6α-ethylchenodeoxycholic acid (6ECDCA), a potent and selective agonist for the Farnesoid X Receptor (FXR)Steroids, 2012
- Farnesoid X receptor targeting to treat nonalcoholic steatohepatitisDrug Discovery Today, 2012
- Farnesoid X Receptor Agonist for the Treatment of Liver and Metabolic Disorders: Focus on 6-ethyl-CDCAMini-Reviews in Medicinal Chemistry, 2011
- Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure−Activity Relationship of a Series of Body and Side Chain Modified Analogues of Chenodeoxycholic AcidJournal of Medicinal Chemistry, 2004